massive pulmonary embolism case pres
TRANSCRIPT
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 1/31
Presented By:
Del Rosario, Pamela Janine T.De Vera, Gazzel M.
Fuentes, Mary Dominica Guballa, Guianne Mishael R.
Magpayo, Allen Jerome R.Padilla, Ma. Patricia T.
Pagcu, Ronald I.Yamon, Abigail Faye A.
Presented to:Michelle Suguitan RN, MSN
August 14, 2013
Massive Pulmonary EmbolismCase Presentation
St. Jude College
School of Nursing Don Quijote Street, Sampaloc, Manila
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 2/31
HISTORY:
55-year-old female nursing home resident with past medical histo
dilated cardiomyopathy (estimated left ventricular ejection fractio
previous transthoracic echocardiogram), and prior deep venous th
was found to be hypotensive and in respiratory distress while at hnursing facility.
She was brought to the emergency department, where vital signs
for temperature of 100.9ºF, HR=142/min, BP=90/60 mmHg after in
fluids, with oxygen saturation of 99% while breathing 100% oxyge
rebreather mask. Computed tomography of the chest with pulmoprotocol revealed large, thrombi in the right main and left main p
arteries with incomplete occlusion, in addition to multiple segmen
right upper, middle and lower lobes. No lower extremity deep vei
were noted on venogram. Anticoagulation was initiated and the p
transferred to the intensive care unit (ICU) for further managemen
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 3/31
OBJECTIVES
• To be able to describe and explain massive pulmonary emtogether with the risk factors contributing to the occurrencondition.
• Review the anatomy and physiology of the organ involved
• Correlate the results in the laboratory and diagnostic prodone
with the patient including their purposes and specific nuresponsibilities before, during and after the procedure.
• Enumerate the different medications for the disease condtheir indications and specific nursing responsibilities befoand after medication administration.
INTRODUCTION
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 4/31
BIOGRAPHICAL DATA • Name: GM
• Age: 55 years old
• Gender: Female
• Address: Pampanga
• Civil Status: Married
• Nationality: Filipino
•
Insurance Coverage: N/A• Admitting Medical Diagnosis: Massive Pulmonary Embolism
• Reason for seeking health care/chief complaint during admissiDifficulty breathing
• Past Medical History: AIDS, Dilated Cardiomyopathy, Deep VeinThrombosis
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 5/31
PHYSICAL ASSESSMENT
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 6/31
BODY PARTS FINDINGS ANALYSIS
EYES Pupil 3mm reactive,
Eye deviated
Pupils normal in size; eye deviation may indic
ORAL CAVITY Lips and mucous
membrane pale
May indicate decreased hemoglobin
SPEECH Expressive aphasia Damage to the broca’s area
THORAX Chest pain Due to the presence of pulmonary embolism
LUNGS Presence of Bilateral
crackles
Due to pulmonary embolism
Tachypnea Indicates hypoxemia
HEART S3 and S4 gallop S3, murmurs; Indicates CHF
Tachycardia Cardiac compensation
ABDOMEN Soft and nontender normal
LOWER
EXTREMITIES
Presence of grade 1+
edema
Accumulation of fluid in the interstitial compa
Cold to touch Accumulation of fluid due to venous system c
to pulmonary embolism and dilated cardiomy
Right sided weakness Due to neurological involvement of the right s
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 7/31
Diagnostic Tests
E i i N l l Fi di A l i
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 8/31
Examination Normal values Findings Analysis
Na (sodium) 133-145
mmol/L
134mmol/L Normal
K (potassium) 3.5-5.0 mmol/L 4.6 mmol/L Normal
HCO3 (bicarbonate) 22-26 mEq/L 13 mEq/L Low, indicates metabolic alkalos
BUN 10-20 mg/dL 45 mg/dL High, decreased cardiac output
perfusion & reduction in glomer
leading to inadequate eliminatio
nitrogenous wastes
Creatinine 0.5-1.5 mg/dL 2.8 mg/dL Slightly elevated, may indicate c
s. glucose 60-110 mg/dL 102 mg/dL Normal
troponin 0.08mg/ml 2.7mg/ml High, indicates MIABG:
pH 7.35-7.45 7.32 Slightly low, indicates acidosis
PaCo2 35-45 25 mmHg Low, indicate compensatory resp
PaO2 85-95 mmHg 250 mmHg High, may , indicate compensato
or may also Indicate polycythem
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 9/31
ABG’S(ICU) prior to
intubation
Actual findings Normal findings Interpre
pH 7.32 7.35-7.45 A decrea
and PaCO2metabolic
(p. 297)
and sudda
edit
PaCO2 25 mmHg 35-45 mm HgPaO2 71 mmHg 70-100 mm Hg
Laboratory findings:
Actual findings Normal findings Interpretation
Negative Negative Normal
Guaiac test ( Fecal Occult Blood Test)
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 10/31
Actual findings Interpretation
-Dilated left ventricular with
depressed systolic function
-Moderate tricuspid regurgitation anddilated inferior vena cava noted
Stretching distorts the valve an
supporting structures, prevent
valve closure due to hercardiomyopathy (p.906) Lemo
Burke 3rd edition
ECG(echocardiogram)
Actual findings InterpretationPulmonary emboli in bilateral pulmonary
artery
Thrombus that completely or partia
obstruct the pulmonary artery or it
causes increased dead space and e
impairment of gas exchange (p.582
and suddarths 12th edition
CT scan (Chest)
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 11/31
ANATOMY
AND
PHYSIOLOGY
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 12/31
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 13/31
PATHOPHYSIOLOGY
RF: Dilated cardiomyopathy, Deep vein thrombosis, hypertension
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 14/31
blood stasis, vessel injury, hypercoagulability
Thrombus formation
Dislodgement of thrombus or portion of thrombus
Migration of thrombus to pulmonary circulation
Occlusion of the pulmonary artery Substances released from the clot & surrounding area (ex.thrombox
prostaglandin & endothelin) causes blood vessel and bronchioles con
Area in the lungs that is continued to
be ventilated but little/no blood flow
occurs ( increased dead space)
Decreased oxygen levels inthe blood
Detection of respiratory center of
this hypoxemic state
Compensatory tachypnea and
tachycardia
Increased pulmonary vascular resistance and pulmonary arterial pres
Increased workload on the right ventricle
(when ventricular workload exceeds its capacity )
Decreased COCHFsystemic hypotension
Renal hypoperfusion destruction of renal parenchyma
Inability of the body to eliminate nitrogenous and other wastes
Increased BUN,Creatinine levels, oliguria
(over time)
Chronic kidney disease
Dyspnea, chest pa
hypoxemia
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 15/31
Nursing Care Plans
A t Di i Pl i I t ti R ti l
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 16/31
Assessment Diagnosis Planning Intervention Rationale
Skin warm to touch
Flushed skin
Presence of foley catheter
Vital signs as follow:
T-39oC
RR-30cpmPR-140bpm
BP-80-60mmHg
Hyperthermia
related to infectious
process secondary
to Foley catheter
insertion
Analysis:Pyrogens cause a
rise in body
temperature; it also
acts as an antigen
triggering immune
system responses.
The hypothalamus
reacts to raise the
set point and body
respond by
producing heat.
Reference :
Fundamentals of
Nursing pg 488
Within 2 hours of
nursing intervention
the patient temperature
will lower down to
normal level:
T-36.5-37.5 C
Independent:
Assess the causative
factor(site of foley
catheter)
Monitor vital signs
Provided tepidsponge bath
Provide cool
circulating
environment
Dependent :
Administered
antipyretic such as
ASA
Maintain IV fluid as
ordered
Swelling and
discharge of t
indicates infe
Notes progre
changes of condition
Enhances hea
by evaporatio
conduction
Dissipates he
convection
Antipyretic re
fever by its ce
action on the
hypothalamu
Prevents
dehydration
Assessment Diagnosis Planning Intervention Rationale
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 17/31
Assessment Diagnosis Planning Intervention Rationale
OBJECTIVE
T-39
Pr-140
Rr-30
Bp-80/60-Presence of S3 and
S4 upon auscultation
-Presence of grade 1
bilateral edma on
lower extremities
-Cold clammy skin
Subjective:-chest pain
-dyspnea
-abdominal pain
Ineffective tissue
perfussion
Analysis:
Decrease in
oxygen resultingin the failure to
nourish the
tissues at the
capillary level.
(Nurses pocket
guide p.705)
Within 2
hours of
nursing
intervention
s patient’svital signs
will be at
normal
range.
Independent:
-Monitor Bp, ABG’s, and
laboratory values
-Evaluate vital signs,
noting changes in Bp,heart rate and
respiratory rate.
-Monitor the condition
of the skin (lower
extremities)
for edema and skin
temp.-Auscultate heart and
lung sounds frequently.
-Elevate head of the bed
Administer fursemide as
ordered
-Provides
comparison with
current findings.
(Nurses pocketguide p.705)
-to promote
circulation and
venous drainage
-used to decrease
edema
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 18/31
Drug Study
NAME OF MECHANISM DOSAGE INDICATIONS CONTRAINDICATION SIDE
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 19/31
DRUG OF ACTION EFFECTS
Heparin
Drug Class:
Anticoagulant
Prevents
conversion of
fibrinogen to
fibrin and
prothrombin
to thrombin by
enhancing
inhibitory
effects of
antithrombin
III
1000 units
in 20ml
D5W
-prevention of
DVT
-pulmonary
emboli
-MI
Hypersensitivity
Leukemia with
bleeding
Severe
thrombocytopenic
purpura
Fever, chills,
hematuria,
hemorrhage
anemia,
rash,
dermatitis,
anaphylaxis
NAME OF MECHANISM OF DOSAGE INDICATIONS CONTRAINDICATION SIDE
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 20/31
DRUG ACTION EFFECTS
Abacavir
Drug
Class:
Antiviral
A synthetic
nucleoside analog
with inhibitory
action against HIV.
Inhibits replication
of the virus by
incorporating into
cellular DNA by
viral reverse
transcriptase,
therebyterminating the
cellular DNA chain.
500 mg IV
q6hrs
(ANST)
In combination
with other
antiretroviral
agents for HIV-1
infection
Hypersensitivity
Lactic acidosis
Fever,
headache,
malaise,
insomnia,
nausea,
vomiting,
diarrhea,
cramps, ras
dyspnea,
lactic
acidosis
NAME OF MECHANISM DOSAGE INDICATIONS CONTRAINDICATION SIDE
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 21/31
NAME OF
DRUG
MECHANISM
OF ACTION
DOSAGE INDICATIONS CONTRAINDICATION SIDE
EFFECTS
Clopidogrel Inhibits first
and second
phases of
ADP-
induced
effects in
platelet
aggregation
50mg/
tab 1tab
PO OD
-reducing the
risk of stroke
-MI
-peripheral
arterial
disease in
high risk pts.
-acute
coronarysyndrome
-transient
ischemic
attack
Hypersensitivity
Active bleeding
Headache
dizziness,
GI
bleeding,
epistaxis,
bleeding,
cough,
bronchitis
NAME OF MECHANISM OF DOSAGE INDICATIONS CONTRAINDICATION SIDE EFFECT
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 22/31
DRUG ACTION
Enalapril Selectively
suppresses
renin-
angiotensin-
aldosterone
system; inhibits
ACE; prevents
conversion of
angiotensin I to
angiotensin II,
dilation orarterial, venous
vessels
10mg/tab
1tab OD PO
Hypertension
CHF
Left ventricular
dysfunction
-hypertension
-angioedema
Dysrhythmia
MI,
Orthostatic
hypotension,
proteinuria,
renal failure,
neutropenia.
NAME OF MECHANISM DOSAGE INDICATIONS CONTRAINDICATION SIDE EFFECTS
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 23/31
DRUG OF ACTION
Levetiracetam Unknown,
may inhibit
nerve impulse
by limiting
influx of sodium ions
across cell
membrane in
minor cortex
5mg/tab
2tabs
q12hrs PO
Adjunctive
therapy in
partial onset
seizure
Hypersensitivity Dizziness,
somnolence,
asthenia,
abdominal
pain,pharyngitis.
DRUG NAME MECHANISM OF DOSAGE INDICATION CONTRAINDICATI ADVERSE EFFEC
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 24/31
ACTION ON
furosemide
Drug class: loop
diuretics
Inhibits reabsorption
of sodium and chloride
from the proximal and
distal tubules and
ascending limb of the
loop of Henle, leading
to a sodium-richdiuresis.
-40 mg/tab 1tab OD,
PO
-20 mg TIV
-Treatment of
hypertension
-Acute pulmonary
edema
-Contraindicated with
hypersensitivity to
furosemide,
sulphonamides
-Use cautiously with
Diabetes mellitus
CNS: headache,
dizziness, insomnia
CV: Hypotension
Derma: rash, pruritus
urticaria, dry skin
GI: diarrhea, abdomi
pain, nausea,constipation, dry mo
GU: Polyuria, nocturi
glycosuria
DRUG NAME MECHANISM OFACTION
DOSAGE INDICATION CONTRAINDI-CATION
ADVERSE EFFECTS
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 25/31
ACTION CATION
aspirin (ASA)
Drug class:
Antiplatelet,
Antipyretic
-Inhibition of
platelet
aggregation is
attributable to
the inhibition of
platelet synthesis
of thromboxane
A2
-Antipyretic
effects are not
fully understood,
but it acts in the
thermoregulatory
center of thehypothalamus to
block the effects
of endogenous
pyrogen by
inhibiting
synthesis of
prostaglandin
intermediary
80 mg/tab-1
tab OD, PO
-for fever
-reduction of risk of
recurrent TIA’s and
CVA in patients with
history of TIA
-reduction of risk of
death or nonfatal MI
in patients with
history infarction or
unstable angina
pectoris or
suspected acute MI
-Contraindicated
with allergy to
salicylates or
NSAID’s, Aspirin,
bleeding defects,
blood coagulation
defects
Acute aspirin
toxicity: respiratory
alkalosis,
tachypnea,
hemorrhage,
confusion,
pulmonary edema,
fever, metabolic
acidosis, seizures
GI: nausea,
epigastric
discomfort,
anorexia
Salicylism:dizziness, tinnitus,
vomiting, diarrhea,
confusion,
lassitude
-A
a
-
t
-
in
c
-
s
w
o
-
t
um
-
m
a
-
im
c
DRUG NAME MECHANISM OF DOSAGE INDICATION CONTRAINDI- ADVERSE
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 26/31
ACTION CATION EFFECTS
epinephrine
(adrenaline)
Drug class:
-Alpha-adrenergic
agonist
-Beta1 and Beta 2-adrenergic agonist
-Bronchodilator
-Cardiac stimulant
-Mydriatic
-Sympathomimetic
Naturally occurring
neurotransmitter, the
effects of which are
mediated by alpha or
beta receptors target
organs. Effects of alphareceptors include
vasoconstriction,
contraction of dilator
muscles of iris. Effects
on beta-receptors
include positive
chronotropic and
inotropic effects on the
heart; bronchodilation,
vasodilation.
5 mcg/min TIV -Relief from
respiratory
distress
-Prophylaxis of
cardiac arrest
and attacks of transitory AV
heart block
-Contraindicated
with hypersensitivity
to epinephrine or
components of
preparation,
tachyarrhythmias,hypertension, renal
impairment,
ischemic heart
disease, cardiac
dilation
-use cautiously with
CAD, elderly
CNS: dizziness,
light headedne
headache,
fatigue, letharg
GI: nausea,
abdominaldiscomfort,
Derma: Allergi
reactions (rash
pruritus)
CV: arrhythmia
tachycardia,
palpitaitons
GU: decrease
urine formatio
dysuria,
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 27/31
Nurse’s Progress Notes
DATE TIME NURSING NURSING INTERVENTION
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 28/31
PROBLEMS
8-13-13 10:15 >Respiratory
distress
>difficulty of
breathing
>position the patient at semi fowlers po
>administer oxygen via non-rebreather m
>vital signs taken: BP-80-90mmHg, RR-3
140BPM, Temp-39
10:30 >ABG obtained results: pH-7.04, CO2-38
>ECG obtained results: sinus tachycardia
beats.
>administered heparin drip 5000unit in
units/hour
>prepare patient for chest CT scan and o
consent
10:40 >assisted ET tube insertion performed by
10:45 >echocardiogram obtained, results: left
depressed systolic function moderate tr
regurgitation and dilated inferior vena ca
DATE TIME NURSING NURSING INTERVENTION
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 29/31
PROBLEMS8-13-13 1:00 >Hyperthermia
>Hypotension
>administered PNSS 1L to run for 12h
>administered PNSS 1L to run for 12h
2:00 >Progressive DOB >assisted in endotracheal intubation; ET changed
hooked patient to mechanical ventilator
>requested radiologic department for chest xray tplacement
>assessed chest expansion; symmetrical
>auscultated chest fields, crackles heard bilaterall
>repositioned patient and suctioned secretions as
3:00 >Oliguria >weighed underpads soaked with urine, initial out
catheterization 150g in 3h>inserted foley catheter, urine output on the 1st h
20cc,3rd hour-0
>administered furosemide 20mg IV, after 30 min.
4:00 >Hyperthermia >checked proper regulation of PNSS
>performed tepid sponge bath
>administered antipyretics as ordered
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 30/31
DISCHARGE PLAN
MEDICATIONS Take the medications as prescribed and avoid skipping. Contact physician if adnoticed such as itching and difficulty of breathing
7/27/2019 Massive Pulmonary Embolism Case Pres
http://slidepdf.com/reader/full/massive-pulmonary-embolism-case-pres 31/31
noticed such as itching and difficulty of breathing.
Always check with health care provider before taking any medicine, including
medications.
Wear an identification bracelet or carry a medicine card stating that taking an
EXERCISE Walk occasionally and do active exercise of moving legs and ankles while sittin
TREATMENT Avoid stressful and exhausting moments for this also can aggravate symptomperiods every day is very beneficial and effective.
HEALTH
EDUCATION
Report the occurrence of dark, tarry stools to the health care provider immed
Continue to wear antiembolism stockings as long as directed.
Avoid sitting with legs crossed or sitting prolonged periods of time.
Look for bruising and bleeding when taking anticoagulants and to avoid bump
Avoid laxatives because they may affect vitamin K absorption (Vitamin K prom
Use toothbrush with soft bristles to prevent gum injury/gingival bleeding
OUTPATIENT
FOLLOWUP
Attend to physician’s follow up check-up (Two weeks after discharge) at the o
Be sure to ask the physician about modifications with regards to medications,
examinations to be done.
DIET Instruct adequate fluid intake.
Instruct client to increase intake of nutritious food such as vegetables and fru
SPIRITUALEncourage client to have positive outlook in life, pray for continuous recovery